DEA suggests 2nd comment period for post-PHE online Rx registration

The DEA’s two days of curated listening sessions showcased ideas for how a special registration eliminating in-person evaluation requirements for medically necessary controlled substances might work, but the agency indicated a need for more specifics.

Powered by WPeMatico